Duration of intra-aortic balloon pump use and related complications

References

• Saia F, Grigioni F, Marzocchi A, Branzi A. Management of acute left ventricular dysfunction after primary percutaneous coronary intervention for ST elevation acute myocardial infarction. Am Heart J. 2010;160:S16–S21.
   Google Scholar
• Bahekar A, Singh M, Singh S, Bhuriya R, Ahmad K, Khosla S, et al. Cardiovascular outcomes using intra-aortic balloon pump in high-risk acute myocardial infarction with or without cardiogenic shock: a meta-analysis. J Cardiovasc Pharmacol Ther. 2012;17:44–56.
   PubMed Web of Science ®Google Scholar
• Gu J, Hu W, Xiao H, Feng X, Chen Y, Zhang D. Intra-aortic balloon pump improves clinical prognosis and attenuates C-reactive protein level in acute STEMI complicated by cardiogenic shock. Cardiology 2010;117:75–80.
   Google Scholar
• Sanborn TA, Sleeper LA, Bates ER, Jacobs AK, Boland J, French JK, et al. Impact of thrombolysis, intra-aortic balloon pump counterpulsation, and their combination in cardiogenic shock complicating acute myocardial infarction: A report from the shock trial registry. Should we emergently revascularize occluded coronaries for cardiogenic shock?J Am Coll Cardiol. 2000;36(Suppl. A):1123–9.
   Google Scholar
• Brodie BR, Stuckey TD, Hansen C, Muncy D. Intraaortic balloon counterpulsation before primary percutaneous transluminal coronary angioplasty reduces catheterization laboratory events in high-risk patients with acute myocardial infarction. Am J Cardiol. 1999;84:18–23.
   Google Scholar
• Thiele H, Sick P, Boudriot E, Diederich KW, Hambrecht R, Niebauer J. Randomized comparison of intra-aortic balloon support with a percutaneous left ventricular assist device in patients with revascularized acute myocardial infarction complicated by cardiogenic shock. Eur Heart J. 2005;26:1276–83.
   PubMed Web of Science ®Google Scholar
• Seyfarth M, Sibbing D, Bauer I, Fröhlich G, Bott-Flügel L, Byrne R, et al. A randomized clinical trial to evaluate the safety and efficacy of a percutaneous left ventricular assist device versus intra-aortic balloon pumping for treatment of cardiogenic shock caused by myocardial infarction. J Am Coll Cardiol. 2008; 52:1584–8.
   PubMed Web of Science ®Google Scholar
• Cheng JM, den Uil CA, van der Ent M, Jewbali LS, van Domburg RT, et al. Percutaneous left ventricular assist devices vs. intra-aortic balloon pump counterpulsation for treatment of cardiogenic shock: a Ameta-analysis of controlled trials. Eur Heart J. 2009;30:2102–8.
   PubMed Web of Science ®Google Scholar
• Perera D, Stables R, Thomas M, Booth J, Pitt M, Blackman D, et al; BCIS-1 Investigators. Elective intra-aortic balloon counterpulsation during high-risk percutaneous coronary intervention a randomized controlled trial. JAMA. 2010;304:867–74.
   PubMed Web of Science ®Google Scholar
• Thiele H, Zeymer U, Neumann FJ, Ferenc M, Olbrich HG, Hausleiter J, et al. Intraaortic balloon support for myocardial infarction with cardiogenic shock. N Engl J Med. 2012;367: 1287–96.
   PubMed Web of Science ®Google Scholar
• Boudoulas KD, Pederzolli A, Saini U, Gumina RJ, Mazzaferri EL Jr, Davis M, et al. Comparison of Impella and intra-aortic balloon pump in high-risk percutaneous coronary intervention: Vascular complications and incidence of bleeding. Acute Card Care. 2012;14:120–4.
   Google Scholar
• Parissis H, Soo A, Al-Alao B. Intraaortic balloon pump: Literature review of risk factors related to complications of the intraaortic balloon pump. J Cardiothorac Surg. 2011;6:147.
   Google Scholar
• Valente S, Lazzeri C, Crudeli E, Chiostri M, Giglioli C, Bernardo P, et al. Intraaortic balloon pump: Incidence and predictors of complications in the Florence registry. Clin Cardiol. 2012;35:200–4.
   PubMed Web of Science ®Google Scholar
• Sjauw KD, Engström AE, Vis MM, van der Schaaf RJ, Baan J Jr, Koch KT, et al. A systematic review and meta-analysis of intra-aortic balloon pump therapy in ST-elevation myocardial infarction: Should we change the guidelines?Eur Heart J. 2009;30:459–68.
   PubMed Web of Science ®Google Scholar
• Mahmoudi M, Hauville C, Gaglia MA Jr, Sardi G, Torguson R, Xue Z, et al. The impact of intra-aortic balloon counter-pulsation on in-hospital mortality in patients presenting with anterior ST-elevation myocardial infarction without cardiogenic shock. Cardiovasc Revasc Med. 2012;13:328–30.
   Google Scholar
• Ohman EM, George BS, White CJ, Kern MJ, Gurbel PA, Freedman RJ, et al. Use of aortic counterpulsation to improve sustained coronary artery patency during acute myocardial infarction. Results of a randomized trial. The randomized IABP study group. Circulation 1994;90:792–9.
   PubMedGoogle Scholar
• Stone GW, Marsalese D, Brodie BR, Griffin JJ, Donohue B, Costantini C, et al. A prospective, randomized evaluation of prophylactic intraaortic balloon counterpulsation in high risk patients with acute myocardial infarction treated with primary angioplasty. Second primary angioplasty in myocardial infarction (PAMI-II) trial investigators. J Am Coll Cardiol. 1997;29:1459–67.
   PubMedGoogle Scholar
• van't Hof AW, Liem AL, de Boer MJ, Hoorntje JC, Suryapranata H, Zijlstra F. A randomized comparison of intra-aortic balloon pumping after primary coronary angioplasty in high risk patients with acute myocardial infarction. Eur Heart J. 1999;20:659–65.
   PubMed Web of Science ®Google Scholar
• Mejia VM, Naidu SS, Hermann H. Support devices for high-risk percutaneous coronary interventions. In: Topol EJ, editor. Textbook of interventional cardiology 5th edition. Philadelphia, PA: Saunders Elsevier; 2008. pp. 643–4.
   Google Scholar
• Trost JC, Hillis LD. Intra-aortic balloon counterpulsation. Am J Cardiol. 2006;97:1391–8.
   PubMed Web of Science ®Google Scholar
• Williams DO, Korr KS, Gewirtz H, Most AS. The effect of intraaortic balloon counterpulsation on regional myocardial blood flow and oxygen consumption in the presence of coronary artery stenosis in patients with unstable angina. Circulation 1982;66:593–7.
   PubMed Web of Science ®Google Scholar
• Kern MJ, Aguirre F, Bach R, Donohue T, Siegel R, Segal J. Augmentation of coronary blood flow by intraaortic balloon pumping in patients after coronary angioplasty. Circulation 1993;87:500–11.
   PubMedGoogle Scholar
• Prondzinsky R, Unverzagt S, Russ M, Lemm H, Swyter M, Wegener N, et al. Hemodynamic effects of intra-aortic balloon counterpulsation in patients with acute myocardial infarction complicated by cardiogenic shock: The prospective, randomized IABP shock trial. Shock 2012;37:378–84.
   Google Scholar
• Cook DJ, Reeve BK, Guyatt GH, Heyland DK, Griffith LE, Buckingham L, et al. Stress ulcer prophylaxis in critically ill patients. Resolving discordant meta-analyses. JAMA. 1996;275: 308–14.
   PubMed Web of Science ®Google Scholar
• Cook DJ, Witt LG, Cook RJ, Guyatt GH. Stress ulcer prophylaxis in the critically ill: A meta-analysis. Am J Med. 1991;91:519–27.
   PubMed Web of Science ®Google Scholar
• Alhazzani W, Alenezi F, Jaeschke RZ, Moayyedi P, Cook DJ. Proton pump inhibitors versus histamine 2 receptor antagonists for stress ulcer prophylaxis in critically ill patients: A systematic review and meta-analysis. Crit Care Med. 2013;41:693–705.
   PubMed Web of Science ®Google Scholar